Loading…
Loading…
| # | Schedule | Awarded To | Bids | Value |
|---|---|---|---|---|
| 1 | Schedule 1 | ARADHYA MEDICALSLikely | 11 | ₹159 |
| 2 | Schedule 2 | KUNDAN LIFESCIENCESLikely | 11 | ₹6,000 |
| 3 | Schedule 3 | Not yet disclosed by govt.Likely | 31 | - |
| 4 | Schedule 4 | Not yet disclosed by govt.Likely | 31 | - |
| 5 | Schedule 5 | Not yet disclosed by govt.Likely | 31 | - |
Tender Value
₹96,100
EMD Value
Exempted
Closing Date
2 Jun 2025, 11:00 amClosed
Atomoxetine 10 mg Tab
Atorvastatin 20 mg Tab
Atropine Sulphate 0.6 mg 1 ml Inj
Azithromycin Dihydrate 250 mg Tab
Baclofen 10 mg Tab
7830174
GEM/2025/B/6221856
Two Packet Bid
Atomoxetine 10 mg Tab
30 days
Rajasthan; Ajmer
Item wise evaluation
BOQ
3 documents required · 3 mandatory
10%
Exempted
2 Jun 2025
12 May 2025
2 Jun 2025
| Item No | Item Title | Description | Qty | Unit | Consignee | Delivery (days) |
|---|---|---|---|---|---|---|
| 1 | Atomoxetine 10 mg Tab | As per pdf | 300 | No | AJMER | 30 |
| 2 | Atorvastatin 20 mg Tab | As per pdf | 15,000 | No | AJMER | 30 |
| 3 | Atropine Sulphate 0.6 mg 1 ml Inj | As per pdf | 150 | Amp OBLIQUE Vial | AJMER | 30 |
| 4 | Azithromycin Dihydrate 250 mg Tab | As per pdf | 3,000 | No | AJMER | 30 |
| 5 | Baclofen 10 mg Tab | As per pdf | 2,000 | No | AJMER | 30 |
Tap a document below to read it instantly. You can also download everything as a ZIP if you prefer.
bid_7830174.pdf
GEM_BID
dglp_medicine_03_2025-05-12-10-20-02_310f8298e420298df48942d34e1c4a5e.pdf
BOQ
dglp_medicine_03_2025-05-12-10-20-02_b2bf4fe8864e6a1b81ec71850ca5f091.csv
BOQ
list-of-categories-where-trials-are-allowed_1712126171.pdf
OTHER
gtc.pdf
OTHER
Download all tender documents and submit your bid
Disclaimer: TenderKart has made every reasonable effort to ensure that the information on this page is accurate and authentic, however it cannot be held liable for any third-party claims or losses or any damages. TenderKart makes no warranty, expressed or implied, as to the results obtained from the use of this information. If you notice any error or omission, please let us know at .